Concepedia

Anjili Mathur

AM

Statistics

Publications

10

Citations

335

H-Index

10

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

SUNY Upstate Medical University

Anjili Mathur is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, neuroscience, and molecular neuroscience.

Publications per year

2000–2014

10

Publications

10

MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation

Li Wang, Kathy A. Mason, K. Kian Ang et al. · Investigational New Drugs · 2011 · 85 citations

, , +10

Astrocytes express specific variants of CaM KII ? and ?, but not ? and ?, that determine their cellular localizations

Mary Lou Vallano, Carol M. Beaman‐Hall, Anjili Mathur et al. · Glia · 2000 · 73 citations

, , +13

FGFR2 Is Amplified in the NCI-H716 Colorectal Cancer Cell Line and Is Required for Growth and Survival

Anjili Mathur, Christopher Ware, Lenora J. Davis et al. · PLoS ONE · 2014 · 45 citations · Full text

, , +16

Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons

Edward A. Monaco, Carol M. Beaman‐Hall, Anjili Mathur et al. · Biochemical Pharmacology · 2004 · 33 citations

, , +10

The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: Hit to lead

Tony Siu, Ekaterina S. Kozina, Joon Jung et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 27 citations · Full text

, , +12

1–5 of 10